Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4354 | a survey Wiki | 1.00 |
| drug1670 | HADS Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013315 | Stress, Psychological NIH | 0.18 |
| D001008 | Anxiety Disorders NIH | 0.14 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Predi-COVID is a prospective cohort study composed of people positively tested for COVID-19 in Luxembourg, followed digitally for monitoring participants' health evolution and symptoms at home. Participants will be actively followed for 14 days from the time of confirmation of diagnosis, whether they are at the hospital or at home in isolation or quarantine. Short evaluations will be also performed at week 3 and week 4 and then monthly for a period up to 12 months to assess potential long term consequences of COVID-19. A subsample of 200 participants will be contacted to integrate complementary clinical data and collect samples. The study aims at identifying factors associated with the COVID-19 disease severity. COVID-19 patients with severity criteria will be compared to patients with mild disease managed at home. A deep phenotyping related to the symptoms of the disease as well as biosampling allowing for laboratory-based and computational analytics will be performed.
Description: Number of symptoms associated with Covid-19
Measure: Description of clinical manifestations Time: 1 yearDescription: Number of hospitalizations
Measure: Clinical aggravation of the infection Time: 1 yearDescription: Number of discharges
Measure: Discharge of hospitalization Time: 1 yearDescription: Number of deaths
Measure: Death Time: 1 yearDescription: Whole blood count parameters
Measure: Description of biological manifestations Time: 1 yearDescription: Plasma cytokine levels
Measure: Description of biological manifestations Time: 1 yearDescription: Antibodies to SARS-Cov2
Measure: Description of biological manifestations Time: 1 yearDescription: HLA genotypes
Measure: Patient-related prognostic factors Time: 1 yearDescription: Coinfections
Measure: Patient-related prognostic factors Time: 1 yearDescription: Virus mutations
Measure: Virus-related prognostic factors Time: 1 yearDescription: Audio feature extracted from 30 seconds recordings of participants' voice reading a prespecified text, collected throughout the CoLIVE LIH smartphone app.
Measure: Vocal biomarker of Covid-19 related respiratory complications Time: 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports